World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
77
Citations
18787
World Ranking
1844
National Ranking
164

Peter L. Stern publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter L. Stern sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 272 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter L. Stern D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter L. Stern sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter L. Stern is affiliated with the University of Manchester in the United Kingdom. Their research spans medicine with a focus on epidemiology, oncology, infectious diseases, immunology, and otorhinolaryngology.

The scientist's work covers several main topics, including:

  • Cervical Cancer and HPV Research
  • Hepatitis B Virus Studies
  • Cancer Immunotherapy and Biomarkers
  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Head and Neck Cancer Studies

Recent papers authored by Peter L. Stern include:

  • Key steps in vaccine development (2020), published in Annals of Allergy Asthma & Immunology
  • Harnessing immunity for therapy in human papillomavirus driven cancers (2021), published in Tumour Virus Research
  • Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors (2021), published in Viruses
  • Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia? (2023), published in Tumour Virus Research
  • Filling a blank canvas (2020), published in Science

The frequent co-authors collaborating with Peter L. Stern are:

  • Lawrence Banks
  • Tina Dalianis

Their publications appear mainly in the following venues:

  • Tumour Virus Research
  • Science
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Annals of Allergy Asthma & Immunology
  • Viruses

Best Publications

  • IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS

    Federico Garrido;Francisco Ruiz-Cabello;Teresa Cabrera;Juan J. Pérez-Villar

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • Natural history of HLA expression during tumour development

    Federico Garrido;Teresa Cabrera;Angel Concha;Susan Glew

  • The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.

    Ryan D Guest;Robert E Hawkins;Natalia Kirillova;Eleanor J Cheadle

  • Epithelial-mesenchymal transition events during human embryonic stem cell differentiation.

    Angela M Eastham;Helen L Spencer;Francesca Soncin;Sarah Ritson

  • Opportunities and challenges for human papillomavirus vaccination in cancer

    Richard B. S. Roden;Peter L. Stern

  • Prognostic significance of p53 overexpression in gastric and colorectal carcinoma

    T Starzynska;Michael Bromley;Anna K Ghosh;Peter L Stern

  • Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

    Christy Ralph;Eyad Elkord;Deborah J. Burt;Jackie F. O'Dwyer

  • Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

    Sai Daayana;Eyad Elkord;U Winters;M Pawlita

  • Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

    Andreas M Kaufmann;Peter L Stern;Elaine M Rankin;Harald Sommer

  • The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer.

    J R Ellis;P J Keating;J Baird;E F Hounsell

  • Loss of MHC class‐I expression in cervical carcinomas

    Mary E. Connor;Peter L. Stern

  • Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.

    El-Said Abdel-Hady;Pierre Martin-Hirsch;Margaret F Duggan-Keen;Peter L Stern

  • Immunohistological distribution of 5T4 antigen in normal and malignant tissues.

    P. J. Southall;G. M. Boxer;K. D. Bagshawe;N. Hole

  • Loss of HLA class I expression in prostate cancer: implications for immunotherapy.

    Rosemary A. Blades;Patrick J. Keating;Lorna J. McWilliam;Nicholas J.R. George

  • Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.

    Emma J Davidson;Christopher M Boswell;Peter Sehr;Michael Pawlita

  • TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical Neoplasia

    Renske D. M. Steenbergen;Debbie Kramer;Boudewijn J. M. Braakhuis;Peter L. Stern

  • Therapy of Human Papillomavirus-Related Disease

    Peter L. Stern;Sjoerd H. van der Burg;Ian N. Hampson;Thomas R. Broker

  • Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

    Richard W Griffiths;Eyad Elkord;David E Gilham;Vijay A C Ramani

  • Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

    P J Keating;F Cromme;Margaret F Duggan-Keen;P J Snijders

Frequent Co-Authors

Henry C Kitchener
Henry C Kitchener University of Manchester
Robert E. Hawkins
Robert E. Hawkins University of Manchester
Eyad Elkord
Eyad Elkord Xi’an Jiaotong-Liverpool University
Richard B.S. Roden
Richard B.S. Roden Johns Hopkins University
Catharine M L West
Catharine M L West University of Manchester
Federico Garrido
Federico Garrido University of Granada
Francisco Ruiz-Cabello
Francisco Ruiz-Cabello University of Granada
Chris J.L.M. Meijer
Chris J.L.M. Meijer Vrije Universiteit Amsterdam
Michael Pawlita
Michael Pawlita German Cancer Research Center
Kensaku Mori
Kensaku Mori University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology, expanding your expertise with related healthcare degrees can open diverse career opportunities. Many students pursue advanced nursing roles that focus on psychiatric and acute care specialties, which complement immunological knowledge.

For example, finding pmhnp programs online with best clinical placement is ideal for those aiming to become Psychiatric Mental Health Nurse Practitioners. These programs ensure strong clinical experiences that are vital for career success.

If affordability is a priority, exploring the cheapest psych np programs online offers quality education without excessive financial burden. This can make advanced degrees more accessible while maintaining educational standards.

Understanding compensation trends is equally important. Those with a Doctor of Nursing Practice degree should research dnp salary by specialty to gauge potential earnings based on their chosen focus area and location.

Additionally, nurses seeking to expand their scope can consider an fnp to acnp bridge program online. This pathway supports transitioning from Family Nurse Practitioner to Acute Care NP roles, providing advanced skills to address critical patient needs.

Best Scientists Citing Peter L. Stern

Trending Scientists

Recently Published Articles